Concepedia

Risk-based Screening Intervals

Risk-Based Screening Intervals is a clinical guideline framework that stratifies individual breast cancer risk to determine personalized mammography screening frequencies, distinguishing it from fixed-interval population screening by adapting surveillance intensity to patient-specific risk profiles.

57

Publications

2.8K

Citations

419

Authors

211

Institutions

Publications per year

2017–2026

31

Parents

Publications

57

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

John T. Wei, Daniel A. Barocas, Sigrid Carlsson et al. · The Journal of Urology · 2023 · 352 citations · Full text

, , +17

A deep learning system for predicting time to progression of diabetic retinopathy

Ling Dai, Ting‐Li Chen, Qiang Wu et al. · Nature Medicine · 2024 · 302 citations · Full text

, , +16

Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer

Ester Vilaprinyó, Carles Forné, Misericòrdia Carles-Lavila et al. · PLoS ONE · 2014 · 152 citations · Full text

, , +17

Incidence and reinfection rates of genital chlamydial infection among women aged 16 24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group

D. Scott LaMontagne, Kathleen Baster, Lynsey Emmett et al. · Sexually Transmitted Infections · 2006 · 147 citations · Full text

, , +17

Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening

Peter H. Scanlon, S J Aldington, José Leal et al. · Health Technology Assessment · 2015 · 139 citations · Full text

, , +17

1–5 of 57

Authors

419

  1. EA
    Eveline A.M. Heijnsdijk

    Erasmus MC, Netherlands

    4 publications · 95 citations

    4

    h-index

  2. HJ
    Harry J. de Koning

    Erasmus MC, Netherlands

    4 publications · 198 citations

    4

    h-index

  3. IS
    Irene Stratton

    Oxford Centre for Diabetes, Endocrinology and Metabolism, United Kingdom

    4 publications · 251 citations

    4

    h-index

  4. AG
    Ann G. Zauber

    Memorial Sloan Kettering Cancer Center, United States

    3 publications · 154 citations

    3

    h-index

  5. AN
    Anna N.A. Tosteson

    Dartmouth College, United States

    3 publications · 192 citations

    3

    h-index

1–5 of 419

Institutions

211

  1. Erasmus MC

    Rotterdam, The Netherlands

    8 h-index

    43 publications

    3.1K citations

  2. Erasmus University Rotterdam

    Rotterdam, The Netherlands

    5 h-index

    20 publications

    365 citations

  3. University of California, San Francisco

    San Francisco, United States

    5 h-index

    22 publications

    2.4K citations

  4. Cheltenham General Hospital

    Cheltenham, United Kingdom

    4 h-index

    8 publications

    612 citations

  5. Memorial Sloan Kettering Cancer Center

    New York, United States

    4 h-index

    7 publications

    995 citations

  6. University of Manchester

    Manchester, United Kingdom

    4 h-index

    27 publications

    2.6K citations

  7. University of Washington

    Seattle, United States

    3 h-index

    4 publications

    423 citations

  8. University of North Carolina at Chapel Hill

    Chapel Hill, United States

    3 h-index

    3 publications

    89 citations

1–8 of 211

Venues

  1. Cancer

    4 publications · 243 citations

    4

    h-index

  2. Diabetologia

    4 publications · 121 citations

    4

    h-index

  3. JNCI Journal of the National Cancer Institute

    3 publications · 136 citations

    3

    h-index

  4. Nature Medicine

    2 publications · 318 citations

    3

    h-index

  5. American Journal of Preventive Medicine

    2 publications · 32 citations

    2

    h-index

1–5